OCUMENSION-B: (I) PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; AND (II) PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME
Ocumension Therapeutics-B: (1) REFRESHMENT OF THE SCHEME MANDATE LIMIT AND SETOF THE SERVICE PROVIDER SUBLIMIT;(2) GRANT TO EMPLOYEE PARTICIPANTS AND CONNECTEDTRANSACTION INVOLVING THE PROPOSED CONNECTED GRANT;AND(3) NOTICE OF EXTRAORDINARY GENERAL ME
Ocumension Therapeutics-B: DELAY IN DESPATCH OF CIRCULAR IN RELATION TO PROPOSEDCONNECTED GRANT TO DIRECTORS UNDER THE2021 SHARE AWARD SCHEME
Ocumension Therapeutics-B: (I) GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME;(II) GRANT OF AWARDS TO EMPLOYEES UNDERTHE 2021 SHARE AWARD SCHEME; AND(III) NON-EXEMPT CONNECTED TRANSACTION - PROPOSEDCONNECTED GRANT TO DIRECTORS
Ocumension Therapeutics-B: GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEMEANDGRANT OF AWARDS UNDER THE 2021 SHARE AWARD SCHEME
Ocumension Therapeutics-B: COMPLETION OF ISSUE OF UNLISTED WARRANTS UNDER SPECIFIC MANDATE
Ocumension Therapeutics-B: (1) PROPOSED ADOPTION OF THE 2021 SHARE OPTION SCHEME;(2) PROPOSED GRANT OF OPTIONS UNDERTHE 2021 SHARE OPTION SCHEME;(3) CONNECTED TRANSACTION INVOLVING PROPOSED GRANTOF AWARDS UNDER THE 2021 SHARE AWARD SCHEME;(4) PROPOSE
Ocumension Therapeutics-B: DELAY IN DESPATCH OF CIRCULAR IN RELATIONTO PROPOSED ADOPTION OF 2021 SHARE OPTION SCHEME,PROPOSED GRANT OF OPTIONS AND PROPOSED GRANTOF AWARDS UNDER 2021 SHARE AWARD SCHEME
Ocumension Therapeutics-B: (I) PROPOSED ADOPTION OF 2021 SHARE OPTION SCHEME ANDPROPOSED GRANT OF OPTIONS;(II) ADOPTION OF 2021 SHARE AWARD SCHEME; AND(III) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED GRANTOF AWARDS TO DIRECTORS
Ocumension Therapeutics-B: CLARIFICATION ANNOUNCEMENT IN RELATION TOPLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDERS
Ocumension Therapeutics-B: INSIDE INFORMATIONPLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDERS
Ocumension Therapeutics-B: (I) DISCLOSEABLE TRANSACTIONS RELATING TO THE EXCLUSIVELICENSE AGREEMENT AND THE SHARE PURCHASE AGREEMENTAND(II) THE WARRANT SUBSCRIPTION AGREEMENTWITH ALIMERA SCIENCES, INC.
Ocumension Therapeutics-B: COMPLETION OF PLACING OF EXISTING SHARESAND TOP-UP SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Ocumension Therapeutics-B: PLACING OF EXISTING SHARESTOP-UP SUBSCRIPTION OF NEW SHARESUNDER GENERAL MANDATE
Ocumension Therapeutics-B: GREEN APPLICATION FORM
Ocumension Therapeutics-B: YELLOW APPLICATION FORM
Ocumension Therapeutics-B: WHITE APPLICATION FORM
Ocumension Therapeutics-B: GLOBAL OFFERING
No Data